Related Experiment Video

Updated: Oct 11, 2025

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.7K

Potential prognostic and predictive role of baseline circulating tumor cells in head and neck squamous cell carcinoma

Anshika Chauhan1, Rajandeep Kaur1, Sushmita Ghoshal2

  • 1Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.

Oral Oncology
|November 30, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.7K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.0K

Related Experiment Videos

Last Updated: Oct 11, 2025

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

8.7K
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

8.7K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.0K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K

Articles linked to this work by shared authors, journal, and citation graph.

Incidence, Predictors, and Course of Hepatocellular Carcinoma Following Direct-Acting Antivirals Therapy in a Prospective Genotype-3 Predominant HCV Elimination Compensated Cirrhosis Cohort.

Journal of clinical and experimental hepatology·2026

Enabling technologies for neural and biofluid interfaces: biocompatible materials with potential for neurodegenerative disease applications.

Biomedical engineering letters·2026

Hydrocolloid-flavor interactions in food systems: A review of mechanisms, factors, and applications.

Food chemistry·2026

Prevalence of hepatitis B and C markers in blood donors deferred from donating blood due to hepatitis-related risk factors.

Asian journal of transfusion science·2026

Identification of epithelial, mesenchymal, and platelet-associated circulating tumour cells with translational implications in oral squamous cell carcinoma.

Scientific reports·2026

Recalibration of the European Kidney Function Consortium eGFR Equation for the Indian Population.

Kidney international reports·2026

Transoral robotic versus laser surgery for cT1-T3 supraglottic laryngeal cancers: a systematic review and meta-analysis of comparative and non-comparative studies.

Oral oncology·2026

Prognostic significance and predictors of pathological response following neoadjuvant paclitaxel, carboplatin, and cetuximab therapy in head and neck squamous cell carcinoma.

Oral oncology·2026

Treatment pathways for oral tongue or floor of mouth reconstruction: A comparative analysis of islanded facial artery myomucosal flap and free anterolateral thigh flap.

Oral oncology·2026

Differential prognostic value of PD-L1 expression in oropharyngeal squamous cell carcinoma based on HPV status.

Oral oncology·2026

Differential associations between treatment delay and survival across head and neck cancer subsites: a national hospital-based framework for risk-stratified prioritization.

Oral oncology·2026

Surgical salvage improves survival for recurrent oral cavity and oropharyngeal squamous cell carcinoma in the era of immunotherapy.

Oral oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us